BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 15946491)

  • 1. Validation of droplet digital PCR for cytokeratin 19 mRNA detection in canine peripheral blood and mammary gland.
    Tanvetthayanont P; Yata T; Boonnil J; Temisak S; Ponglowhapan S
    Sci Rep; 2022 Aug; 12(1):13623. PubMed ID: 35948591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing blood versus tissue-based biomarkers expression in breast cancer patients.
    Oloomi M; Moazzezy N; Bouzari S
    Heliyon; 2020 Apr; 6(4):e03728. PubMed ID: 32274439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
    Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between the mRNA levels of carcinoembryonic antigen and cytokeratin 19 in peripheral blood with staging, treatment response and prognosis in patients with lung cancer].
    Wang JH; Zhang SC; Liu ZD; Chen XY; Li CY; Han Y; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):773-6. PubMed ID: 16324274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
    Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
    Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow micrometastasis in breast cancer.
    Ozbas S; Dafydd H; Purushotham AD
    Br J Surg; 2003 Mar; 90(3):290-301. PubMed ID: 12594663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammaglobin: a candidate diagnostic marker for breast cancer.
    Zehentner BK; Carter D
    Clin Biochem; 2004 Apr; 37(4):249-57. PubMed ID: 15003725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells.
    Pantel K; Otte M
    Semin Cancer Biol; 2001 Oct; 11(5):327-37. PubMed ID: 11562175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of cytokeratin 19 in bone marrow of patients with breast cancer].
    Li BJ; Huang XP; Wei WD; Wang JY; Su XD; Zhang X; Hong WS; Tang J; Zhang LJ; Long H; Yang MT; Rong TH
    Ai Zheng; 2005 Jun; 24(6):735-9. PubMed ID: 15946491
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.